Multiplex fluorescent quantitative PCR (polymerase chain reaction) detection reagent for synchronously detecting four infectious infertility-related hepatitis viruses

By designing multiple fluorescence quantitative PCR technology with specific primers and probes, the problem of the inability to detect four hepatitis viruses simultaneously in the existing technology is solved, and fast and accurate detection is achieved, with high sensitivity and specificity, suitable for infertility Clinical application of infertility and pregnant women.

CN119061201APending Publication Date: 2024-12-03KUNMING UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411321595.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art cannot detect hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis E virus (HEV) and hepatitis G virus (HGV) at the same time quickly and accurately. Traditional single-weight PCR is time-consuming and costly. High and multiply fluorescence-free quantitative PCR method is used for clinical diagnosis.

Method used

Design specific primers and probes to conduct highly conservative sequence matching of four hepatitis viruses, adopt multiple fluorescence quantitative PCR technology, optimize the reaction program and reaction system through the Aikeri one-step kit to achieve simultaneous detection of four reaction systems in one reaction system and determine the Ct value.

Benefits of technology

It realizes the detection of four hepatitis viruses simultaneously in one reaction system, which has high sensitivity, strong specificity and good repeatability. It can quickly and accurately distinguish four viruses, reduces the detection cost, and is suitable for infertility and pregnant women. Large-scale application of special groups.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061201A_ABST
    Figure CN119061201A_ABST
Patent Text Reader

Abstract

The invention discloses a multiplex fluorescent quantitative PCR (Polymerase Chain Reaction) detection reagent for synchronously detecting four infectious infertility-related hepatitis viruses. The detection reagent comprises specific primers and probes aiming at hepatitis B virus, hepatitis C virus, hepatitis E virus and hepatitis heptavirus; according to the present invention, the multiple fluorescence quantitative detection method is adopted, the four hepatitis viruses can be simultaneously detected in the single reaction tube, the virus load can be quantified while the virus infection condition is detected, and the great advantage is provided for the research of the influence of the virus infection state on the clinical disease. The reagent has the advantages of being high in specificity, sensitivity, repeatability and reproducibility, easy to operate and the like, the clinical screening speed of the four hepatitis viruses can be increased, the detection cost can be saved, and the reagent has high application value for clinical rapid screening diagnosis and clinical disease research.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of hepatitis virus detection, and specifically relates to a multiplex fluorescent quantitative PCR detection reagent capable of simultaneously detecting four infectious infertility-related hepatitis viruses. Background Art

[0002] Infertility is a male or female reproductive system disease, which refers to the failure to achieve pregnancy despite normal sexual life without any contraceptive measures for more than one year. Infertility is mainly caused by male factors, female factors, mixed male and female factors, and some unexplained reasons. According to data released by WHO, more than 40 viruses, bacteria, and protozoa can cause infertility after infecting human tissues or reproductive tract. The latest research shows that infection with four types of hepatitis viruses can cause reproductive system abnormalities and affect human reproductive ability, such as hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis E virus (HEV), and hepatitis G virus (HGV). Therefore, in addition to causing liver diseases such as hepatitis, cirrhosis, and liver cancer, hepatitis virus infection can also cause extrahepatic damage, such as infertility.

[0003] Hepatitis B virus is a double-stranded DNA virus belonging to the family Hepadnaviridae. Many studies have shown that HBV infection may lead to many adverse pregnancy outcomes, including premature birth, gestational diabetes, antepartum hemorrhage, preeclampsia, stillbirth and miscarriage. Hepatitis C virus is a single-stranded positive-strand RNA virus belonging to the family Flaviviridae and the genus Hepatitis C virus. It is mainly transmitted through blood, sexual intercourse and mother-to-child transmission. Studies have shown that vertical transmission can occur after HCV infection, especially in women with high HCV viral load or HIV co-infection. In addition, studies have found that the reproductive capacity of women of childbearing age will decline after HCV infection, which may be related to decreased ovarian function and follicular failure. Hepatitis E virus is a single-stranded RNA virus. HEV will infect the ovaries and uterus of women and proliferate to produce new virus particles. Subsequently, HEV will enter the fertilized egg during the fertilization process of the oocyte, and thus transmit the HEV virus to the embryo, ultimately achieving vertical transmission of HEV. During this process, after the ovaries are infected with HEV, the epithelial cells will disperse, necrotize, and fall off, a large number of lymphocytes will infiltrate the ovarian stroma, and apoptosis will occur in oocytes. At the same time, HEV infection will affect embryonic development and cause death in pregnant women. Hepatitis G virus is an enveloped positive-strand RNA virus belonging to the Flaviviridae family. Studies have shown that HGV can exist in semen and may cause infertility.

[0004] In addition, hepatitis virus infection during pregnancy is a major safety hazard for both the mother and the fetus. Vomiting and indigestion during pregnancy can lead to insufficient liver glycogen reserves, ultimately increasing the probability of viral hepatitis. Hepatitis virus infection in late pregnancy can easily develop into severe hepatitis, which can lead to increased incidence of miscarriage, premature birth, neonatal death, and maternal mortality. During pregnancy, hepatitis viruses can infect the fetus through vertical transmission, and because the fetus carries the hepatitis virus for a long time, it is more likely to develop cirrhosis, primary liver cancer, etc. during its later growth and development. The "Clinical Practice Guidelines for Viral Hepatitis in Pregnancy" published by the American College of Obstetricians and Gynecologists pointed out that regardless of the test history and vaccination status, women of childbearing age who are preparing for pregnancy need to undergo HBV and HCV screening before each pregnancy, and carry out appropriate management and treatment before pregnancy, before delivery, during delivery, and after delivery to reduce the risk of vertical transmission and ensure the health of pregnant women and fetuses.

[0005] At present, the main detection methods for hepatitis viruses include enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay (CLIA), loop-mediated isothermal amplification (LAMP), real-time fluorescence quantitative PCR, etc. Although ELISA and CLIA methods have been applied to the clinical detection and screening diagnosis of hepatitis virus antigens or antibodies, the detection results of antigens or antibodies cannot accurately determine the infection status of the virus. At the same time, the LAMP technology has greatly limited its widespread application in clinical diagnosis due to its accuracy and complexity. In contrast, real-time fluorescence quantitative PCR has become an important tool for laboratory and clinical diagnosis of pathogen infection, but traditional single-plex PCR only uses a pair of primers and probes, can only detect one target virus genome at a time, and is time-consuming and has high single-detection costs.

[0006] So far, there is no targeted multiplex fluorescence quantitative PCR method for the simultaneous detection of HBV, HCV, HEV and HGV in clinical practice. Summary of the invention

[0007] In view of the shortcomings of the existing technology, the present invention provides a multiplex fluorescent quantitative PCR detection reagent for simultaneously detecting four infectious infertility-related hepatitis viruses. It uses efficient and rapid molecular detection technology to carry out large-scale hepatitis virus infection screening on clinical samples of infertile people, revealing the epidemic characteristics and transmission patterns of hepatitis viruses in infertile people and their impact on infertility, which is of great value and significance.

[0008] To achieve the above purpose, the present invention designs specific primers and probes for the highly conserved sequences of hepatitis B virus, hepatitis C virus, hepatitis E virus, and hepatitis G virus respectively;

[0009] The specific primers for hepatitis B virus were CTCGTGGTGGACTTCTCTCAATTTTC and CATACCTTGRTARTCCAGAAGAACC, and the probe was CAGCAGGATGMAGAGGAAKATGATAAAA CGCC;

[0010] The specific primers for HCV were CCCGCRAGAYYRCTAGCCGAG and CTCATGDTGCACGGTCTACGA, and the probe was TACTGCCTGATAGGGTGCTTGCGAGTGC;

[0011] The specific primers for hepatitis E virus were TCRTGYTTYTGCCTATGYTGCC and GAATCAACCCKGTCACCCCAGAAAC, and the probe was ACYGCCGYTGCGCCGCCCRC;

[0012] The specific primers for hepatitis G virus are GCCTGATGGTGCTAATGC and GGTGCACCCCTTCAGATC, and the probe is AGCCCGTAGTCACGGATTACGCTATAA.

[0013] The detection reagents of the present invention also include other conventional reagents used for multiplex fluorescence quantitative PCR detection.

[0014] The method of using the above-mentioned multiplex fluorescence quantitative PCR detection reagent is as follows:

[0015] 1. Collect clinical plasma and reproductive tract samples from infertile people (male reproductive tract samples are semen, and female reproductive tract samples are vaginal swabs). During sampling, systematically collect relevant clinical information of infertile patients, register them, store them at low temperature during transportation, and then store them at -80℃;

[0016] 2. Use Tiangen Virus Genomic DNA / RNA Extraction Kit to extract hepatitis virus genomic DNA or RNA from the blood;

[0017] 3. Using the DNA or RNA extracted in step 2 as a template, specific primers and probes for the four hepatitis viruses were used to perform multiplex fluorescence quantitative PCR detection according to the reaction procedure and reaction system optimized by the Acry One-Step Kit (Ag11713), and the results were determined according to the Ct value; the reaction procedure was reverse transcription at 42°C for 5 min, pre-denaturation at 95°C for 30 s; denaturation at 95°C for 20 s, annealing at 55°C for 30 s, extension at 72°C for 30 s, and 40 cycles; the fluorescence signal was collected during the extension stage of each cycle.

[0018] The interpretation of the test results includes the following: (1) The amplification curve presents a standard "S" shape without abnormal fluctuations. If there is no Ct value in the negative control group and the no-template control group, the experiment is considered valid. If it does not meet the requirements, multiplex fluorescence quantitative PCR detection must be performed again, or nucleic acid must be re-extracted for quadruple fluorescence quantitative PCR detection; (2) If the Ct value of hepatitis B virus and hepatitis E virus is ≤34.0, and the Ct value of hepatitis C virus and hepatitis G virus is ≤36.0, it is positive. If 36.0 (34.0) < Ct ≤40.0, it is negative; (3) If the CT value shows UNDFT, the sample is below the detection limit and the result is negative.

[0019] Compared with the prior art, the present invention has the following advantages and technical effects:

[0020] The present invention designs specific primers based on the highly conserved regions of the conserved genes of the four hepatitis viruses, and utilizes specific probes for different viruses with different labels to achieve simultaneous detection of the four hepatitis viruses in one reaction system, and can quantify the viral load while detecting the viral infection status.

[0021] The specificity verification of this method found that there was no cross-reaction between the hepatitis viruses and other pathogens, and the specificity was good; the sensitivity verification of the method found that the minimum detection limit of the four hepatitis viruses could reach 100 copies / μL, indicating that the method has high sensitivity; the repeatability verification of the method found that the coefficient of variation of both intra-batch repeatability and inter-batch repeatability was less than 4%, indicating that the repeatability and reproducibility of the method are good.

[0022] The method of the present invention has the advantages of high sensitivity, strong specificity, good repeatability and simple operation. It can detect HBV, HCV, HEV and HGV four viruses simultaneously, quickly and accurately, and provides an effective technical means for laboratory detection to distinguish these four viruses; the development of a one-tube multiplex fluorescent quantitative PCR detection reagent and technical method for synchronously detecting four infectious infertility-related hepatitis viruses and its large-scale application in special populations such as infertile women and pregnant women have important clinical value and significance for studying the pathological connection and pathogenic mechanism of extrahepatic diseases such as infertility and adverse pregnancy outcomes caused by hepatitis virus infection. At the same time, since HBV, HCV, HEV and HGV are all common hepatitis virus types with generally high prevalence rates, this method is also suitable for screening and diagnostic applications of these four hepatitis viruses in the general clinical population and high-risk populations of liver disease patients. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The amplification curves of different probe concentrations of hepatitis B virus are shown;

[0024] Figure 2The amplification curves of different probe concentrations of hepatitis C virus are shown;

[0025] Figure 3 The amplification curves of different probe concentrations of hepatitis E virus are shown;

[0026] Figure 4 The amplification curves of different probe concentrations for hepatitis G virus are shown below;

[0027] Figure 5 The amplification curves of hepatitis B virus at different annealing temperatures are shown;

[0028] Figure 6 The amplification curves of hepatitis C virus at different annealing temperatures are shown;

[0029] Figure 7 The amplification curves of hepatitis E virus at different annealing temperatures are shown;

[0030] Figure 8 The amplification curves of hepatitis G virus at different annealing temperatures are shown;

[0031] Fig. 9 It is the specific experimental result of multiplex fluorescence quantitative PCR;

[0032] Fig.10 To verify the amplification curve results of the linear interval of hepatitis B virus by multiplex fluorescence quantitative PCR;

[0033] Fig.11 To verify the amplification curve results of the linear interval of hepatitis C virus by multiplex fluorescence quantitative PCR;

[0034] Fig.12 To verify the amplification curve results of the linear interval of hepatitis E virus by multiplex fluorescence quantitative PCR;

[0035] Fig.13 To verify the amplification curve results of the linear interval of hepatitis G virus by multiplex fluorescence quantitative PCR;

[0036] Fig.14 This is the result diagram of the standard curve of hepatitis B virus multiplex fluorescence quantitative PCR;

[0037] Fig.15 This is the result diagram of the standard curve of multiple fluorescence quantitative PCR of hepatitis C virus;

[0038] Fig.16 This is the result diagram of the standard curve of multiple fluorescence quantitative PCR of hepatitis E virus;

[0039] Fig.17 This is the standard curve result of hepatitis G virus multiplex fluorescence quantitative PCR. DETAILED DESCRIPTION

[0040] In order to further explain the technical means and effects adopted by the present invention, the technical scheme of the present invention is further explained by specific implementation methods below, but the present invention is not limited to the scope of the embodiments. It should be pointed out that the materials used in the following embodiments are not limited to the above-mentioned materials and can be replaced by other similar materials. If the specific conditions of the instruments are not specified, they are in accordance with conventional conditions or the conditions recommended by the manufacturer. Those skilled in the art should master the relevant knowledge of using conventional materials and instruments; the methods in the embodiments are all conventional methods unless otherwise specified;

[0041] Example 1: Design of specific primers and probes

[0042] 1. Download the full-length genomic nucleic acid sequences of hepatitis B virus, hepatitis C virus, hepatitis E virus, and hepatitis G virus from the NCBI website;

[0043] 2. Use Mega11 software to compare nucleic acid sequences, find out the conserved gene regions of each hepatitis virus genome, and use Primer Select software to design specific primers and probes for the hepatitis B virus P gene, hepatitis C virus 5'UTR gene, hepatitis E virus ORF2 gene, and hepatitis G virus 3'UTR gene;

[0044] 3. Primer and probe BLAST evaluation: The primer and probe nucleotide sequences that have been preliminarily designed are compared again using the BLAST search function on the NCBI website to select primer and probe sequences with high specificity;

[0045] The nucleotide sequences of specific primers and probes targeting four infectious infertility-related hepatitis viruses (HBV, HCV, HEV, HGV) are shown in the following table:

[0046]

[0047] Example 2: Establishment of a multiplex fluorescence quantitative PCR method for four hepatitis viruses

[0048] 1. Plasmid construction and verification

[0049] The specific gene sequence of hepatitis B virus (see SEQ ID NO: 1) was connected to the pUC57 vector to synthesize the hepatitis virus positive plasmid A, and the specific gene sequences of hepatitis C virus, hepatitis E virus, and hepatitis G virus (see SEQ ID NO: 2-SEQ ID NO: 4) were connected to the pUC57 vector to synthesize the hepatitis virus positive plasmid B. The plasmid construction was completed by Sangon Biotechnology Co., Ltd.; the concentration was measured by ultraviolet spectrophotometer, and the copy number of the plasmid was calculated according to the length and concentration of each plasmid. The calculation formula is as follows:

[0050]

[0051] The copy number results are shown in the following table:

[0052] Plasmid name Plasmid concentration (ng / μL) Plasmid copy number (copies / μL) Hepatitis virus positive plasmid A 248.45 7.071E+10 Hepatitis virus positive plasmid B 312.3 8.640E+10 ;

[0053] 2. Optimization of multiple fluorescence quantitative reaction system

[0054] The above plasmid standard was diluted tenfold (10 10 -10 1 According to the initial reaction system and reaction conditions recommended in the instructions of the one-step kit (Ag11713) of Acryl, 10 9 ~10 2 Real-time fluorescence quantitative PCR was performed with plasmid standards of 1000 copies / μL. According to the experimental results, positive standards with Ct values ​​between 15 and 30 cycles, high fluorescence intensity, and good amplification curves were selected as templates for reaction system optimization. Finally, a concentration of 10 6 The positive standard with 10 copies / μL was used as a template for system optimization.

[0055] The final concentrations of the upstream or downstream primers of each gene in the reaction system were set to 100nM, 200nM, and 300nM, respectively. The "matrix method" was used to optimize the primer concentrations. The Ct and Std values ​​are shown in the following table. The final concentrations of the probes in the reaction system were 50nM, 100nM, 150nM, 200nM, and 250nM, respectively. The Ct and Std values ​​are shown in the following table. The amplification curve results are shown in Figure 1-4 As shown; the annealing temperatures were 50°C, 53°C, 55°C, 58°C, and 61°C respectively for annealing temperature optimization, and the amplification curve results are shown in Figure 5-8 As shown. Three replicates were set for each gradient, and the average Ct value and Std value were calculated. According to the principles of relatively small Ct value, good amplification curve, "S" shape, high and concentrated fluorescence intensity, and minimal primer dimers, the optimal concentrations of upstream and downstream primers in the reaction system were determined to be 100 nM; the optimal probe concentration was 200 nM; and the optimal annealing temperature was 55°C;

[0056]

[0057]

[0058] The multiplex fluorescence quantitative PCR reaction system was finally determined as follows: 2×One Step RT-qPCR BufferⅡ(probe)12.5μL, pro Taq HSDNA Polymerase(5U / μL)0.5μL, Evo M-MLV RTase Enzyme MixⅡ0.5μL, HBV-F / R 0.25μL each, HCV-F / R 0.25μL each, HEV-F / R 0.25μL each, HGV-F / R 0.25μL each, HBV-P 1μL, HCV-P 1μL, HEV-P 1μL, HGV-P 1μL, template 2μL, make up to 25μL with water;

[0059] The final double fluorescence quantitative PCR reaction program was determined as follows: reverse transcription at 42°C for 5 min, pre-denaturation at 95°C for 30 s; denaturation at 95°C for 20 s, annealing at 55°C for 30 s, extension at 72°C for 30 s, 40 cycles; fluorescence was collected during the extension phase of each cycle.

[0060] Example 3: Verification of the specificity, linear range, sensitivity and repeatability of the primer-probe fluorescence quantitative PCR of the present invention

[0061] 1. Specificity verification of fluorescent quantitative PCR

[0062] The clinically validated nucleic acid-positive viral genome extracts of herpes simplex virus (HSV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), dengue virus (DENV), norovirus (NoV) and 10 6 The plasmid standard with 100 copies / μL was used as a template, and the one with sterile water added was set as a negative control. The specificity of multiplex fluorescence quantitative PCR was verified according to the reaction system and procedure optimized in Example 2.

[0063] The results are as follows Fig. 9 As shown, except for HBV, HCV, HEV, and HGV, the other viruses were not amplified, and there was no cross reaction between the hepatitis virus detection primers and other viral nucleic acid templates, indicating that the method has good specificity.

[0064] 2. Verification of linear interval of fluorescent quantitative PCR

[0065] The positive plasmid standard was diluted to 10 by 10-fold serial dilution method. 9 -10 2 copies / μL, sterile water was used as a negative control, and specific primers and probes for four hepatitis viruses were used respectively, and the linear interval of the present invention was verified according to the optimized reaction system and procedure;

[0066] The results are as follows Figure 10-13 As shown, the amplification curves are 10 from left to right. 9 copies / μL, 10 8 copies / μL, 10 7 copies / μL, 10 6 copies / μL, 10 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL; a standard curve was established with the logarithm of template concentration as the horizontal axis and the number of cycles as the vertical axis, such as Figure 14-17 As shown in the figure, the standard curve constructed based on the highly conserved sequence of HBV has an amplification efficiency of 87.80%, R 2 The standard curve constructed based on the highly conservative sequence of hepatitis C virus has an amplification efficiency of 106.02% and R 2 The standard curve constructed based on the highly conserved sequence of hepatitis E virus had an amplification efficiency of 94.15% and R 2 The standard curve constructed based on the highly conservative sequence of hepatitis G virus has an amplification efficiency of 103.07%, R 2 It is 0.9986, indicating a good linear relationship.

[0067] 3. Verification of sensitivity of fluorescence quantitative PCR

[0068] After linear interval verification, it was preliminarily determined that the minimum detection limit of the four hepatitis viruses was 10 2 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 With four gradients of 100 copies / μL as templates and sterile water as negative control, 20 repeated experiments were carried out using the multiplex fluorescence quantitative PCR detection method according to the optimized reaction system and reaction procedure. If the detection rate could stably reach more than 95%, it would be finally determined as the minimum detection limit.

[0069] The results are shown in the following table. The minimum detection limits of the detection system of the present invention for the four hepatitis viruses are all 100 copies / μL.

[0070]

[0071] 4. Fluorescence quantitative PCR repeatability verification

[0072] In order to verify the repeatability of the multiplex fluorescence quantitative PCR detection method, a concentration gradient of 10 6 -10 2 The plasmid standard with 1000 copies / μL was used as the positive template, and the detection was performed using a Biori FQD-96a real-time fluorescence quantitative PCR instrument. The reaction system and amplification procedure were the same as in Example 2. The fluorescence signal was collected during the extension phase of each cycle, and the repeatability within and between batches was verified respectively;

[0073] Repeat within the batch: 6 gradients, three replicates per gradient, repeated once; Repeat between batches: 6 gradients, three replicates per gradient, repeated three times; record the Ct value each time, calculate the coefficient of variation (CV) according to the following formula, and evaluate the repeatability. If the coefficient of variation (CV) within and between batches calculated based on the Ct value of the experimental results is less than 5%, it can be said that the repeatability and reproducibility are good.

[0074]

[0075] The repeatability verification results are shown in the following table. The results show that the coefficient of variation CV <4%, indicating that the repeatability and reproducibility of the present invention are good;

[0076]

[0077] Example 4: Multiplex fluorescence quantitative PCR detection of clinical samples

[0078] 1. Sample source

[0079] Twenty plasma samples from clinics that were identified as hepatitis virus positive were collected; the one-tube quadruple fluorescence quantitative PCR method established above was used to detect the hepatitis virus distribution characteristics of the 20 samples, and the infection status of the four hepatitis viruses was counted.

[0080] 2. Nucleic acid extraction

[0081] The sample nucleic acid was extracted using the Tiangen virus genome DNA / RNA extraction kit. The specific steps are as follows:

[0082] a. Preparation before the experiment: Before using the Tiangen Virus Genomic DNA / RNA Extraction Kit, add 70 mL and 17 mL of anhydrous ethanol to the rinse solution PW and buffer GD respectively, and prepare the Carrier RNA working solution according to the proportion in the instruction manual according to the number of samples to be extracted in the experiment;

[0083] b. Sample aliquoting: aliquot 200 μL of blood into a new EP tube and add 20 μL of Protein K;

[0084] c. Add 200 μL of the prepared Carrier RNA working solution to the EP tube, vortex and shake, place in a 56°C water bath for 15 minutes, centrifuge and add 250 μL of anhydrous ethanol, shake for 15 seconds and let stand for 5 minutes, at which time a flocculent precipitate will form;

[0085] d. Transfer the flocculent precipitate and the solution mixture to an adsorption column, centrifuge at 8000 rpm for 1 min, discard the waste liquid, add 500 μL of buffer GD, centrifuge at 8000 rpm for 1 min, discard the waste liquid, and place the adsorption column in a collection tube;

[0086] e. Add 600 μL of rinse solution PW, let it stand for 2 minutes, centrifuge at 8000 rpm for 1 minute, discard the waste liquid, put the adsorption column back into the collection tube, and repeat this step twice;

[0087] f. Add 500 μL of anhydrous ethanol, centrifuge at 8000 rpm for 1 min, discard the waste liquid, and then centrifuge at 12000 rpm for 3 min, and discard the waste liquid;

[0088] h. Place the adsorption column in a new RNase-Free centrifuge tube, open the cover of the adsorption column and place it at room temperature for 3 minutes. When the filter membrane in the column is completely dry, add 45μL RNase-Free ddH2O in the middle of the adsorption membrane. After leaving it at room temperature for 5 minutes, centrifuge at 12000rpm for 3 minutes, collect the nucleic acid solution at the bottom of the tube, divide it according to the needs of subsequent experiments, and store it at -80℃ for later use.

[0089] 3. Multiplex fluorescence quantitative PCR detection

[0090] The nucleic acid extracted in step 2 was used as a template. The reaction system was as described in Example 2. The amplification procedure was as follows: reverse transcription at 42°C for 5 min, pre-denaturation at 95°C for 30 s; denaturation at 95°C for 20 s, annealing at 55°C for 30 s, extension at 72°C for 30 s, 40 cycles, and fluorescence was collected during the extension phase of each cycle. The detection results were as follows:

[0091]

[0092] As can be seen from the above table, the reagent of the present invention has the advantages of high sensitivity, strong specificity, good repeatability and simple operation. It can simultaneously, quickly and accurately detect the four viruses of HBV, HCV, HEV and HGV, thereby improving the clinical screening speed of the four hepatitis viruses and saving the detection cost.

Claims

1. A multiplex fluorescence quantitative PCR detection reagent for simultaneous detection of four infectious infertility-related hepatitis viruses, characterized in that: Includes specific primers and probes for hepatitis B virus, hepatitis C virus, hepatitis E virus, and hepatitis G virus; The specific primers for hepatitis B virus were CTCGTGGTGGACTTCTCTCAATTTTC and CATACCTTGRTARTCCAGAAGAACC, and the probe was CAGCAGGATGMAGAGGAAKATGATAAAA CGCC; The specific primers for HCV were CCCGCRAGAYYRCTAGCCGAG and CTCATGDTGCACGGTCTACGA, and the probe was TACTGCCTGATAGGGTGCTTGCGAGTGC; The specific primers for hepatitis E virus were TCRTGYTTYTGCCTATGYTGCC and GAATCAACCCKGTCACCCCAGAAAC, and the probe was ACYGCCGYTGCGCCGCCCRC; The specific primers for hepatitis G virus are GCCTGATGGTGCTAATGC and GGTGCACCCCTTCAGATC, and the probe is AGCCCGTAGTCACGGATTACGCTATAA.